Krsnaa Diagnostics – what is the diagnosis?

Apart from result performance I want to highlight few observation.

i) Now in latest PPT there is no mention of 2x revenue and 3x PAT. Attaching investor presentation snip from last year.

ii) Huge price errosion in CT Scan and MRT Scan

FY22 rates: CT Scan: 2000, MRI: 3500

FY23 rates: CT Scan: 973 (more than 50% price drop) , MRI: 2209 (37% price drop)

There are other examples of misleading for which Management credibility is in question.

PS: Have exited my position recently post Q4 results.